Second-line Surufatinib Combined With Chemotherapy in Advanced CRC

Clinical trial NCT04734249 · UNKNOWN

Trial details

NCT number: NCT04734249
Sponsor: Fujian Cancer Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Colorectal Cancer

Start date: 2021-03-01
Primary completion: 2021-03-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.